A

Aclaris (ACRS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Aclaris (ACRS)

Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a physician-led, biopharmaceutical company focused on immuno-inflammatory diseases. The Company is focused on leveraging its experience in drug discovery and development and kinase inhibit... Read more

  • 15.93
  • 16.38
  • 15.13
  • 18.96
  • 5%
  • 24M
  • 0.00
  • 406.57k
  • 1.1B
  • 9.26
  • 25.9%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.